Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Acta Clinica Croatica|July 21, 2021
Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an observational study of treatment patterns and lipid controlHrvoje Pintarić, Marijana Knezović Florijan, Ian Bridges, et al.
Therapeutic Advances in Cardiovascular Disease|January 6, 2024
Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort studyIsabella Sudano, Stephan Krähenbühl, François Mach, et al.
Cardiovascular Drugs and Therapy|June 1, 2016
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed HyperlipidemiaRobert S Rosenson, Terry A Jacobson, David Preiss, et al.
BMC Nephrology|March 26, 2011
Extended dosing of darbepoetin alfa in peritoneal dialysis patientsMariano Feriani, Johan M J De Meester, Lawrence P McMahon, et al.
Advances in Therapy|February 14, 2019
Clinical Management of High and Very High Risk Patients with Hyperlipidaemia in Central and Eastern Europe: An Observational StudyIvo Petrov, Andreea Dumitrescu, Michaela Snejdrlova, et al.
Journal of Clinical Lipidology|July 2, 2024
Detecting familial hypercholesterolemia: An observational study leveraging mandatory universal pediatric total cholesterol screening in SlovakiaKatarina Raslova, Viera Donicova, Katarina Gonova, et al.
Wiener Klinische Wochenschrift|July 31, 2023
Evolocumab effectiveness in the real-world setting: Austrian data from the pan-European observational HEYMANS studyChristoph Ebenbichler, Heinz Drexel, Ursula Hanusch, et al.
Pageof 3